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of 156 patients with long-term follow-up
Jia-Qin Cai†, Ke Chen†, Yi-Ping Mou*, Yu Pan, Xiao-Wu Xu, Yu-Cheng Zhou and Chao-Jie HuangAbstract
Background: The aim of this study was to compared laparoscopic (LWR) and open wedge resection (OWR) for the
treatment of gastric gastrointestinal stromal tumors (GISTs).
Methods: The data of 156 consecutive GISTs patients underwent LWR or OWR between January 2006 and December
2013 were collected retrospectively. The surgical outcomes and the long-term survival rates were compared. Besides, a
rapid systematic review and meta-analysis were conducted.
Results: Clinicopathological characteristics of the patients were similar between the two groups. The LWR group was
associated with less intraoperative blood loss (67.3 vs. 142.7 ml, P < 0.001), earlier postoperative flatus (2.3 vs. 3.2 days,
P < 0.001), earlier oral intake (3.2 vs. 4.1 days, P < 0.001) and shorter postoperative hospital stay (6.0 vs. 8.0 days, P = 0.001).
The incidence of postoperative complications was lower in LWR group but did not reach statistical significance (4/90,
4.4% vs. 8/66, 12.1%, P = 0.12). No significant difference was observed in 3-year relapse-free survival rate between the
two groups (98.6% vs. 96.4%, P > 0.05). The meta-analysis revealed similar results except less overall complications in
the LWR group (RR = 0.49, 95% CI, 0.25 to 0.95, P = 0.04). And the recurrence risk was similar in two group (RR = 0.80,
95% CI, 0.28 to 2.27, P > 0.05).
Conclusions: LWR is a technically and oncologically safe and feasible approach for gastric GISTs compared with OWR.
Moreover, LWR appears to be a preferable choice with mini-invasive benefits.
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Gastrointestinal stromal tumors (GISTs), the most com-
mon mesenchymal tumor of the gut, are often character-
ized by high expression of KIT [1,2]. The most common
sites for GIST include the stomach (60%) and jejunum
or ileum (30%) followed by duodenum (5%), colon and
rectum (less than 5%), esophagus (less than 1%), and
appendix (less than 1%) [2]. GISTs have malignant po-
tential, and it is reported that recurrence of GISTs often
occured at the peritoneal surface or liver [3]. Surgical* Correspondence: mouyiping2002@163.com
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unless otherwise stated.resection is the mainstay management for primary local-
ized GISTs. As submucosal and lymphatic spread are
rare, the surgical principles are composed of an R0 re-
section with a normal mucosa margin, no systemic
lymph node dissection, and avoidance of perforation,
which results in peritoneal seeding even in cases with
otherwise low risk profiles [2-4].
Since the development of minimally invasive surgical
approaches, laparoscopic surgery for gastrointestinal tu-
mors has evolved rapidly over the past decade. Various
types of laparoscopic approaches for GISTs have been
described, including wedge resection of the stomach,
intragastric tumor resection, and combined endoscopic-
laparoscopic resection [5-8]. For gastric GISTs, lymph
node metastases are rare and localised resection with as is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Cai et al. BMC Surgery  (2015) 15:58 Page 2 of 10clear margin of 1 to 2 cm appears to be an adequate
treatment [9,10]. Besides, recent evidence has shown
that survival depends on the tumor size and histological
features rather than the extent of resection [3]. There-
fore, gastric GISTs can be treated without major ana-
tomical resections [11] and are suitable for laparoscopic
wedge resection (LWR). Several case series have proved
the safety and feasibility of LWR for gastric GISTs, how-
ever, the oncologic benefits of LWR have not been widely
reported and the sample size of those researches were
relatively small. In the current study, we retrospectively
reviewed data for GIST patients who underwent LWR
and traditional open wedge resection (OWR) at our hos-
pital between 2006 and 2013. The clinical data, benefits of
operation, perioperative outcomes, and oncologic outcomes
were reviewed. Besides, a rapid systematic review with a
meta-analysis was conducted to further assess accur-
ately the current status of LWR for gastric GIST.
Methods
Patients
Between January 2006 and December 2013, 177 con-
secutive patients with suspected gastric GIST underwent
laparoscopic or open wedge resection in the Department
of General Surgery at the Sir Run Run Shaw Hospital,
China. The exclusion criteria included: (1) patients con-
comitant with tumors outside stomach; (2) patients with
metastatic disease at the time of operation; (3) patients
diagnosed as other types of submucosal tumor after
immunohistochemical examination. Blood tests, chest
X-rays, enhanced computed tomography scans of the ab-
domen and pelvis, and endoscopic ultrasonography were
performed before operation. This study protocol was
prospectively approved by ethics committee of Sir Run Run
Shaw Hospital, School of Medicine, Zhejiang University
and conducted in accordance with the ethical guidelines
of the Declaration of Helsinki. Informed consent was
signed prior to surgery by each case.
Surgical procedure
The patient is placed in the supine position under gen-
eral anesthesia. The surgeon stood on the right side of
the patient. One assistant stood on the right side of the
patient and held the laparoscope, and another stood on
the left side of the patient. Carbon dioxide pneumoperi-
toneum was established through the Veress needle and
set at 15 mmHg. One initial 10-mm trocar was inserted
for laparoscopy below the umbilicus and another four
trocars (one of 12 mm, three of 5 mm) were inserted
into the left upper flank, left flank, right upper flank,
and right flank quadrants; a total of five trocars were
inserted, and arranged in a V-shape.
Mobilizing the tumor before excised were usually as
fellows: Tumor in anterior wall of the gastric body andpylorus was excised directly. If tumor was in anterior
wall near lesser curvature, the hepatogastric ligament
was dissected firstly to free it. If it was in anterior wall
near great curvature, parts of gastrocolic ligament and
gastrosplenic ligament were dissected firstly. For tumor
located in posterior wall, the gastrocolic and gastrosple-
nic ligament were dissected, then lifted up the stomach
to expose the tumor. Those in fundus, the gastrocolic
and gastrosplenic ligament was also dissected as well as
left gastroepiploic vessels and short gastric vessels, so
the fundus can be mobilized and the tumor can be ex-
pose. Gastroscopy was used intraoperatively to evaluate
tumor localization if necessary. Tumor was excised using
ultrasonic scalpel or endoscopic linear stapler with at
least 1-2 cm surgical margin. The defect left by excision
using ultrasonic scalpel in the gastric wall was reinforced
using laparoscopic hand-suturing technique. If the tu-
mors were near the cardia or pylorus, excision using
ultrasonic scalpel was preferred, as it can reduce the risk
of cardiac or pyloric stricture. While the tumors were in
the gastric fundus, excision using endoscopic linear stap-
ler was preferred, for tumor had a good mobility to per-
form this procedure easily. For tumors located near the
esophagogastric junction, especially those with intralum-
inal growth, we used laparoscopic transgastric wedge re-
section to avoid deformity or stenosis in the gastric inlet.
A summary of the detailed transgastric resection were
described in our published article [6].
Data collection and follow-up evaluation
The patients’ demographic data, surgical outcomes, and
complications were reviewed, and the survival rate was
analyzed. The prognostic indicators of GISTs were based
on tumor size and mitotic index, according to the risk
assessment classification proposed by Fletcher et al. [12]
Gastric GISTs were categorized for malignant potential
as very low risk (<2 cm and <5 mitoses/50 high-power
fields, HPFs), low risk (2–5 cm and <5 mitoses/50
HPFs), intermediate risk (<5 cm and 6–10 mitoses/50
HPFs or 5–10 cm and <5 mitoses/50 HPFs), and high
risk (>5 cm and >5 mitoses/50 HPFs, >10 cm and any
mitotic rate, any size, or >10 mitoses/50 HPFs). The im-
munohistochemical analysis included detection of CD117,
CD34, smooth muscle actin protein (SMA), S-100, and
desmin expression. Follow-up results were obtained from
patients’ medical records and telephone calls, and recur-
rence was determined by endoscopy, computed tomog-
raphy, positron emission tomography, etc, and the last
follow-up day was January 30, 2014.
A rapid systematic review and meta-analysis
We searched PubMed, Cochrane Library, Web of Science
and BIOSIS Previews for literature comparing LWR and
OWR published between January 1995 and April 2014.
Table 1 Clinical characteristics of patients
Variable(%) LWR(n = 90) OWR(n = 66) P value
Gender (male/female) 31/59 29/37 0.79
Age (years) 58.6 ± 10.7 56.8 ± 11.9 0.33
BMI (kg/m2) 22.8 ± 3.1 23.3 ± 3.7 0.29
ASA classification (I/II/III) 44/41/5 33/30/3 1.00
Comorbidities (yes) 35(38.9) 26(39.4) 0.77
Hypertension 29(32.2) 17(25.8)
Diabetes mellitus 9(10) 7(10.6)
Cardiovascular 5(5.6) 4(6.1)
Pulmonary 2(2.2) 1(1.5)
Previous abdominal surgery 22(24.4) 20(30.3) 0.42
Preoperative hemoglobin 12.8 ± 1.9 12.7 ± 2.4 0.91
Preoperative albumin 42.2 ± 4.2 42.9 ± 4.5 0.31
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stromal tumor”, “GIST”, “laparoscopy”, “laparoscopic”,
“minimally invasive surgery”, “gastric resection”, “gastric
surgery”, and “comparative study”. The language of the
publications was confined to English. The papers contain-
ing any of the following were excluded: (1) concomitant
with tumors outside stomach; (2) not wedge resection;
(3) if there was overlap between authors or centers, the
higher quality or more recent literature were selected. Two
investigators reviewed the titles and abstracts, and assessed
the full text to establish eligibility. The Newcastle-Ottawa
Quality Assessment Scale (NOS) was used for quality as-
sessment of observational studies. A threshold of six stars
or above has been considered indicative of high quality.
Statistical analysis
Quantitative data are given as the means ± standard de-
viations (SDs). The differences in the measurement data
were compared using the Student’s t test, and compari-
sons between groups were tested using the χ2 test or the
Fisher exact probability test. Relapse-free survival (RFS)
rates were calculated by the Kaplan-Meier method using
SPSS software, version 18.0 (SPSS Inc, Chicago, United
States). Relapse-free survival was calculated from the day
of surgery to the day of recurrence. P < 0.05 was considered
statistically significant.
The meta-analysis was performed in line with recom-
mendations from the Cochrane Collaboration and the
Quality of Reporting of Meta-Analyses guidelines [13,14].
Continuous variables were assessed using the weighted
mean difference (WMD), and dichotomous variables were
analyzed using the risk ratio (RR). If the study provided
medians and ranges instead of means and standard devia-
tions (SDs), we estimated the means and SDs as described
by Hozo et al. [15]. To account for clinical heterogeneity,
which refers to diversity in a sense that is relevant for clin-
ical situations, we used the random effects model based
on DerSimonian and Laird’s method. Potential publication
bias was determined by conducting informal visual inspec-
tion of funnel plots based on the complications. Data ana-
lyses were performed using Review Manage version 5.1
(RevMan 5.1) software downloaded from the Cochrane
Library. P < 0.05 was considered statistically significant.
Results
Demographic and clinicopathologic characteristics
Among the 177 patients, 21 were excluded. Five pa-
tients with coexistence of any other malignancies were
excluded. Fourteen patients were excluded because
diagnosed as other types of submucosal tumor instead
of GIST. Two patients with metastatic disease were
also excluded. Finally, 156 patients were enrolled into
this study. Among them, 90 patients underwent laparo-
scopic wedge resection (LWR group) for gastric GISTs,while 66 patients received open wedge resection (OWR
group).
The LWR group included 31 males (34.4%), and the
mean age was 58.6 ± 10.7 years. The OWR group in-
cluded 29 males (43.9%), and the mean age was 56.8 ±
11.9 years. Mean body mass index (BMI) for the LWR
was 22.8 ± 3.1 kg/m2 compared with 23.3 ± 3.7 kg/m2
among the OWR. The ASA score for each patient was:
ASA I [LWR, 44 (48.9%); OWR, 33 (50.0%)], ASA II
[LWR, 41 (45.6%); OWR, 30 (45.5%)], and ASA III [LWR,
5 (5.6%); OWR, 3 (4.5%)]. No statistical differences were
observed between the group’s demographic characteris-
tics, ASA scores, comorbidities, and BMI (Table 1). The
mean preoperative hemoglobin and albumin levels were
12.8 ± 1.9 g/dL and 42.2 ± 4.2 g/L in LWR group, and
12.7 ± 2.4 g/dL and 42.9 ± 4.5 g/L in OWR group.
The pathological variables of the patients are summa-
rized in Table 2. The mean tumor size in the LWR
group was 3.5 cm and in the OWR group it was 4.3 cm.
The mean tumor size in the LWR group was smaller
than OWR group (P = 0.02). However, for properties,
there was no statistically significant difference between
the two groups according to Fletcher’s criteria (P > 0.05).
In all GIST patients, 84.6% had a mitotic rate of fewer
than 5 mitoses per 50 high-power field (HPF), 9.6% had
a mitotic rate between 5 and 10 mitoses per 50 HPF, and
5.8% had more than 10 mitoses per 50 HPF. The two
groups were comparable with respect to tumor location,
with the majority of patients having tumors located in
the gastric body or fundus (77.7% in the LWR and 63.6%
in the OWR group).
Operative outcomes and postoperative recovery
The outcomes associated with surgery and postoperative
recovery are shown in Table 3. In the OWR group, the
mean amount of estimated intraoperative bleeding was
more than in the LWR (67.3 ± 80.5 ml vs. 142.7 ± 102.0;
Table 2 Pathologic features of patients
Variable(%) LWR(n = 90) OWR(n = 66) P value




Body near lesser curvature 11(12.2) 4(6.1)
Body near greater curvature 30(33.3) 22(33.3)
Antrum 6(6.7) 14(21.2)
Mitotic rate (per 50 HPF) 0.20
<5 80(88.9) 52(78.8)
5 ~ 10 7(7.8) 8(12.1)
>10 3(3.3) 6(9.1)
Immunohistochemistry
CD117(+) 86(95.6) 66(100) 0.11
CD34(+) 87(96.7) 63(95.5) 0.20
DOG-1(+) 72(80.0) 58(87.9) 0.19
SMA 30(33.3) 17(25.8) 0.31
S-100 16(17.8) 14(21.2) 0.59
Desmin 9(10) 6(9.1) 0.95
Fletcher classification 0.51
Very low risk 20(22.2) 13(19.7)
Low risk 46(51.1) 28(42.4)
Intermediate risk 16(17.8) 16(24.2)
High risk 8(8.9) 9(13.6)
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(106.6 ± 40.1 min vs. 119.9 ± 59.9; P > 0.05). There were 21
cases in the LWR group used intraoperative endoscopy to
locate the tumors.
Mean times to postoperative flatus and oral intake
were significantly shorter in the LWR group than in theTable 3 Operative findings and postoperative clinical
courses
Variable LWR(n = 90) OWR(n = 66) P value
Operation time (min) 106.6 ± 40.1 119.9 ± 59.9 0.12
Blood loss (ml) 67.3 ± 80.5 142.7 ± 102.0 0.000
Intraoperative endoscopy 21(23.3) 0(0.0)
Time to first flatus (days) 2.3 ± 0.9 3.2 ± 0.8 0.000
Time to oral intake (days) 3.2 ± 1.0 4.1 ± 0.9 0.000
Postoperative hospital stay (days) 6.0 ± 2.1 8.0 ± 5.1 0.001
Postoperative complications 4(4.4) 8(12.1) 0.08
Anastomotic hemorrhage 0 2
Abdominal abscess 0 1
Delayed gastric emptying 3 3
Wound infection 0 2
Pulmonary infection 1 0OWR group (2.3 days vs. 3.2 days, P < 0.01, and 3.2 days
versus 4.1 days, P < 0.01). The mean duration of postop-
erative hospital stay was two days longer in the OWR
group (6.0 days vs. 8.0 days, P < 0.01).
The incidence of postoperative complications was
higher for the OWR group than the LWR group. But the
difference did not reach statistical significance (4.4% vs.
12.1%, P = 0.08). Incidences of morbidity in LWR group
included three cases of delayed gastric emptying and
one case of pulmonary infection. Complications in OWR
group included two cases of anastomotic hemorrhage,
one case of abdominal abscess, three cases of delayed
gastric emptying and two cases of wound infection. All
these complications were controlled with conservative
treatment.
Follow-up results
Of the 156 identified patients, 149 (95.5%) were followed
up and 7 were lost to follow-up. Follow-up data were
available for 87 (96.6%) and 62 (93.9%) of patients
treated with LWR and OWR, respectively. The median
follow-up was 21.0 months (range, 1-90 months) in the
LWR group and 44.5 months (range, 1-96 months) in
the OWR group.
One patient in the LWR group diagnosed with low
risk of disease recurrence developed metachronous liver
metastasis 9 months after operation. Two patients in the
OWR group developed liver metastasis 11 months and
24 months after operation, respectively. They were both
diagnosed with high risk of recurrence and were still
alive at the end of last follow-up. One patient of low risk
of recurrence in the LWR group dead of breast cancer
42 months after gastric surgery. However, there was no
evidence of GIST recurrence before her death. The 3-year
RFS rates was 98.6% in LWR group and 96.4% in OWR
group. There were no significant differences between the
two groups (P > 0.05) (Figure 1).
A rapid systematic review and meta-analysis
The initial search strategy retrieved 972 publications in
English. After the titles and abstracts were reviewed,
papers without comparison of LWR and OWR were ex-
cluded, which left 20 comparative studies, fourteen
[9,16-28] of which did not meet the inclusion criteria
and were excluded. This left a total of six comparative
observational studies [29-34]. A flow chart of the search
strategies is illustrated in Figure 2. Including the present
data, a total of 525 patients were included in the analysis
with 264 undergoing LWR (50.3%) and 261 undergoing
OWR (49.7%). According to the NOS, one out of the six
observational studies got 7 stars, two articles got 8 stars,
and the remaining three got 9 stars. The characteristics
and methodological quality assessment scores of the
included studies are shown in Table 4.
Figure 1 Kaplan-Meier relapse-free survival curves of patients
underwent laparoscopic (LWR) or open wedge resection (OWR)
gastric GISTs.
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analysis showed no statistically significant difference in
the operative time of the two groups (WMD= 4.08 min;
95% CI, -20.23 to 28.39; P = 0.74) (Figure 3A). Two studies
reported blood loss [30,34]. Intraoperative blood loss was
significantly lower in the LWR compared with the OWR
group (WMD = -60.02 ml; 95% CI, -76.90 to -43.14 ml;
P < 0.01) (Figure 3B). All studies reported overall complica-
tions [29-34]. There were significantly fewer overall compli-
cations in the LWR than the OWR group (RR = 0.49, 95%
CI, 0.25 to 0.95, P = 0.04) (Figure 3C). Visual inspection of
the funnel plot revealed symmetry, indicating no serious
publication bias (Figure 4). Morbidity was specified in two
studies [31,34]. One study reported a wound infection in
OWR group [31]. Another reported one wound infection
and one anastomosis site bleeding in LWR group and oneFigure 2 Flow chart of literature search strategies.wound infection, one wound dehiscence and four pyrexia
in OWR group [34].
All studies reported duration of hospital stay [29-34].
Patients in the LWR group had a shorter postoperative
hospital stay (WMD= -2.21 days; 95% CI, -3.09 to -1.34,
P < 0.01) (Figure 3D). Four studies reported time to first
flatus [29,30,32,33] and five studies reported time to oral
intake [29,30,32-34]. Patients in the LWR group were
able to pass flatus (WMD = -1.28 days; 95% CI, -1.61 to
-0.96, P < 0.01) (Figure 3E) and resume oral intake earlier
(WMD = -1.51 days; 95% CI, -2.07 to -0.95, P < 0.01)
(Figure 3F).
During the follow-up period, recurrence was observed
in four studies [29,31,32,34]. Including our study, the re-
currence risk in LWR was 2.3% (6/264) and 3.1% (8/261)
in OWR, but the difference between LWR and OWR
was not significant (RR = 0.80, 95% CI, 0.28 to 2.27,
P = 0.67) (Figure 3G). Wan et al. [34] have reported that
there was no significant difference in the 5-year RFS be-
tween LWR and OWR (93.7% in LWR, 95.5% in OWR).
Goh et al. [32] also have reported that there was no
significant differences in RFS between groups.
Discussion
Adenocarcinomas are the most common tumors of the
stomach, whereas submucosal tumors of the stomach
such as GISTs are rare. Unlike adenocarcinomas of gastro-
intestinal tract, GISTs showed that negative macroscopic
margins only may portends a survival benefit [3]. Lymph-
atic spread is quite uncommon, and as such, systemic
lymphadenectomy has been deemed unnecessary [2,3].
These characteristics, along with GISTs’ tendency to grow
in an exophytic manner, led many surgeons prefer wedge
resection rather than formal gastrectomy for gastric GISTs
whenever feasible. Though laparoscopic wedge resection
is expected to be a preferable choice for GISTs compared
with traditional open wedge resection as previously re-
ported [27,29-33,35,36], more convincing evidence is still
needed to prove its safety and feasibility. This manuscript
summarizes the outcomes of LWR of gastric GISTs in the
relatively larger series of patients to date. Our data dem-
onstrate that the patients who underwent LWR for gastric
GISTs results in effective control of the disease with min-
imal perioperative morbidity and no mortality. Besides, a
rapid systematic review with a meta-analysis was con-
ducted to summarize all the published information. We
believe this could help surgeons to share the optimal indi-
vidualized decision for patients.
Our series of patients who underwent LWR had less
intraoperative blooding than that in the OWR group.
The reduced length of incision wound, accurate oper-
ation and the application of energy-dividing devices,
contributed to the reduction of blood loss. Pain after
surgery was milder in LWR than in OWR, reflecting as
Table 4 Summary of studies included in the meta-analysis
Author Nation Study type Publication year Study period Sample size Follow-up (months) Quality scores
LWR OWR LWR OWR
Ishikawa [29] Japan Retro 2006 1993-2004 14 7 60(5–119) 61(3–130) 8
Mochizuki [30] Japan Retro 2006 2000-2004 12 10 26 (6–53) NR 8
Catena [31] Italy Pros 2008 1995-2006 21 25 35(5–58) 91(80–136) 9
Goh [32] Singapore Retro 2010 2001-2009 14 39 8(3–60) 21(2–72) 7
Lee [33] Korea Retro 2011 2001-2008 50 50 21(0–64) 22(0–93) 9
Wan [34] China Retro 2012 2004-2011 63 64 NR NR 9
Retro: retrospective observational study; Pros: prospective observational study; NR: not reported.
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plication [29,32]. The time to first flatus was also earlier
in LWR than in OWR, which indicated more rapid re-
covery of gastrointestinal function after LWR. Reduced
use of analgesic drugs, shortened time of abdominal cav-
ity exposure, alleviated inflammatory reactions, and earl-
ier postoperative activities are considered to be the main
reasons for earlier gastrointestinal recovery from LWR;
all of which may also contribute to shortening the dur-
ation of postoperative hospital stay. The meta-analysis also
revealed these mini-invasive advantages of the LWR.
Interestingly, the operative time in the LWR group did
not longer than OWR which is different from many other
type of laparoscopic surgery [37-42]. This is because the
time-consuming laparoscopic lymphadenectomy is un-
necessary for GISTs resection due to the fact that the
lymphatic metastasis of GISTs is quite rare. As time
spending on the establishment of pneumoperitoneum and
the closure of the trocar incision and minilaparotomy is
likely to shorter than the open and closure of laparotomy,
it is possible that the operative time for the LWR will be
shorter than OWR with the development of the surgical
techniques and laparoscopic instruments.
Regarding the postoperative complication, the inci-
dence was higher in the OWR group than the LWR
group, but the difference did not reach statistical signifi-
cance in our study. However, the meta-analysis indicated
a significant reduction in the LWR group (P = 0.04). In
our study, there was a high incidence of wound problem
in the OWR group. This is also true in included trials
which specified the morbidity [31,34]. It was conceivable
that complications other than wound problem were
similar between groups because LWR results in the same
organ and tissue resection as OWR.
LWR for gastric GISTs seems to have become a popu-
lar technique, the indications for this procedure in rela-
tion to tumor size are still controversial. Large lesions
increase the difficulty to resect using endoscopic linear
staplers and the risk of tumor spillage when removal. It
was previously suggested by the NCCN Guidelines up-
dated in 2007 for Optimal Management of Patients with
GIST that laparoscopic techniques could be approachedfor tumors less than 5 cm [2]. However, many investiga-
tors have reported successful and safe removal of larger
GISTs [26,43-45]. In our series, 12 cases with tumor size
larger than 5 cm underwent LWR successfully with no
conversion, demonstrating its feasibility, though the
mean tumor size of OWR group was slightly larger than
LWR group (4.3 versus 3.5 cm). This observation was
mainly biased by the inherent selection process for pa-
tients to undergo a laparoscopic approach. patients with
smaller tumors may be more amenable to laparoscopy
versus larger tumors, which may tend to treat with
laparoscopy or laparotomy. There were 20 cases in our
series with tumor located near the esophagogastric junc-
tion or the pylorus who were considered inappropriate
to undergo LWR. Performing this procedure has a high
possibility of stenosis or deformity in the gastric inlet or
outlet because it is associated with excessive resection of
the healthy tissue of the gastric wall by laparoscopic
stapling [46]. If the tumor was extraluminal growth, we
resected the tumor using ultrasonic scalpel, then used
laparoscopic intracorporeal handsewn method to close
the incision. With those intraluminal growth, the laparo-
scopic transgastric wedge resection, which provided dir-
ect vision of the lesion and inner stomach, and allows
better control of the surgical margin, was introduced.
Whereas, if the tumor was large, laparoscopic distal or
total gastrectomy was performed instead of LWR which
is impossible in such situation. After tumors removal, all
these cases were confirmed by intraoperative gastro-
scope examination to avoid gastric inlet or outlet nar-
rowing. Currently, there are still no clear consensus
guidelines for gastric GISTs laparoscopic approach based
on tumor size and location. We advocate that tumor size
and location should not be an absolute contraindication
to laparoscopic techniques. However, one thing should be
in mind that regardless laparoscopy or open surgery, it
must be avoid direct tumor manipulation in an effort to
eliminate the incidence of tumor rupture since tumor
spillage can results in shortened disease-free survival [47].
With recent trials confirming the short-term surgical
safety and long-term survival efficacy of laparoscopic
techniques in other gastrointestinal malignancy [48-53],
Figure 3 Meta-analysis of the pooled data. (A) Operative time. (B) Intraoperative blood loss. (C) Overall complications. (D) Postoperative hospital
stay. (E) First flatus. (F) Oral intake. (G) recurrences.
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Figure 4 Funnel plot of the overall postoperative complications.
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the stomach should be clarified. Long-term survival re-
main critical for all patients with GISTs regardless of a
benign or malignant designation since these tumors have
an uncertain biologic behavior. It is widely accepted that
the tumor size and mitotic index are two key factors on
GISTs long-term outcomes. Several recent reports have
also detailed recurrence rates of patients with gastric
GISTs after laparoscopic surgery ranging from 4.8 to
18% [11,26,29,54,55]. In our study, LWR group had a
lower recurrence rate (1.1%) compared to previous re-
ports. This result was mainly due to most of patients in
LWR group with tumors at very low, or low malignant
risk (73.1%), whose recurrence may be delayed for as
long as 10 years [56]. Moreover, in our center patients
with tumors at moderate, or high malignant risk are
routinely recommended to continue treatment with
imatinib after surgery, which can effectively improved
recurrence-free survival and overall survival of GIST
patients with a high risk of GIST recurrence [57,58].
Despite the fact that tumor size of OWR group was larger
than LWR group, two groups were comparable with no
significant difference according to Fletcher’s criteria. Our
series demonstrates the oncologic safety of the laparo-
scopic approach, with efficacy and recurrence rates similar
to open surgical controls. All the tumor-recurrent cases in
our study developed recurrence in 2 years after surgery,
once more proving that most of the GISTs recurrence
occurs within the first 2 years after surgery [3,11,59].
As nonadenocarcinomas in the stomach are uncommon,
the sample of 156 patients is considered large. But it is still
small for definitive conclusions on the safety and effective-
ness of LWR. Thus, our rapid systematic review and
meta-analysis synthesized the existing observationalstudies with strictly limiting inclusion and exclusion cri-
teria. The included studies were primarily derived from
the countries with the most widespread use of laparo-
scopic gastrectomy (two from Japan, one from Korea, one
from China, one from Singapore, and one from Italy), and
the total number of cases incorporated in the study was
525. The larger the number of patients in a meta-analysis,
the greater its power to detect a possible treatment effect.
Therefore, our comprehensive meta-analysis will contribute
to a more systematic and objective evaluation for the safety
and effectiveness of LWR.
There are some limitations to our study. The major
bias was derived from retrospective nature and lack of
prospectively defined inclusion criteria for those under-
going LWR. Also, the majority of cases in our study are
in the past 3 years, which is short for the low risk GISTs
to develop recurrence, and the follow up will continue.
Although the meta-analysis confirmed the mini-invasive
benefits of LWR and the similar postoperative and onco-
logical outcomes between LWR and OWR, the simple
size of some articles included was quite small and there
was no prospective or randomized study that can mark-
edly undermine the strength of the analysis. Our results
should be confirmed by further randomized controlled
trials that compare the open versus laparoscopic approach
for the treatment GISTs.
Conclusions
This study demonstrates laparoscopic wedge resection is a
technically and oncologically safe and feasible approach
for GISTs compared with open wedge resection. More-
over, laparoscopic wedge resection appears to be a prefera-
ble choice with mini-invasive benefits based on our data
and a rapid systematic review with a meta-analysis.
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